Anti-tumorigenicity of dietary α-mangostin in an HT-29 colon cell xenograft model and the tissue distribution of xanthones and their phase II metabolites

Molecular Nutrition and Food Research

Volumn 57, Issue 2, 2013, Pages 203-211

  Chitchumroonchokchai, Chureeporn ^a   Thomas Ahner, Jennifer M ^a,b   Li, Jie ^a   Riedl, Kenneth M ^a,b   Nontakham, Jannarin ^c   Suksumrarn, Sunit ^c   Clinton, Steven K ^a,b   Kinghorn, A Douglas ^a,b   Failla, Mark L ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Mangostin; Catenin protein; BcL 2 protein; Tumor mass; Xenograft

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; BIOLOGICAL MARKER; MANGOSTIN; PROTEIN BCL 2; XANTHONE; XANTHONE DERIVATIVE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BEVERAGE; CELL PROLIFERATION; CELL STRAIN HT29; CELL SURVIVAL; COLON TUMOR; DIET; DRUG EFFECT; DRUG SCREENING; FEMALE; GENETICS; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BETA CATENIN; BEVERAGES; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DIET; FEMALE; HT29 CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PROTO-ONCOGENE PROTEINS C-BCL-2; TISSUE DISTRIBUTION; XANTHONES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

GARCINIA MANGOSTANA; MUS;

EID: 84872793155     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200539     Document Type: Article

References (38)

1. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition Physical Activity, and the Prevention of Cancer: A Global Perspective, AICR, Washington, DC 2007.
2. Pohl, C., Hombach, A., Kruis, W., Chronic inflammatory bowel disease and cancer. Hepato-gastroenterology 2000, 47, 57-70
3. Ramos, S., Cancer chemoprevention and chemotherapy: dietary polyphenols and signaling pathways. Mol. Nutr. Food Res. 2008, 52, 507-526.
4. Sloan, E. W., Getting ahead of the curve: phytochemicals. Nutraceutical World 2010, 13, 16-17.
5. Obolskiy, D., Pischel, I., Siriwatanametanon, N., Heinrich, M., Garcinia mangostana L: a phytochemical and pharmacological review. Phytother. Res. 2009, 23, 1047-1065.
6. Chin, Y. W., Kinghorn, A. D., Structural characterization, biological effects, and synthetic studies on xanthones from mangosteen (Garcinia mangostana), a popular botanical dietary supplement. Mini-Rev. Organ. Chem. 2008, 5, 355-364.
7. Bumrungpert, A., Kalpravidh, R. W., Suksamrarn, S., Chaivisuthangkura, A. et al., Bioaccessibility, biotransformation and transport of α-mangostin from Garcina mangostana (mangosteen) using simulated digestion and Caco-2 human intestinal cells. Mol. Nutr. Food Res. 2009, 53, S54-S61.
8. Chitchumroonchokchai, C., Riedl, K. M., Suksumrarn, S., Clinton, S. K. et al., Xanthones in mangosteen juice are absorbed and partially conjugated by healthy adults. J. Nutr. 2012, 142, 675-680.
9. Doi, H., Shibata, M., Shibata, E., Morimoto, J. et al., Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer. Anticancer Res. 2009, 29, 2485-2496.
10. Nabandith, V., Suzuki, M., Morika, T., Kaneshiro, T. et al., Inhibitory effects of crude α-mangostin, a xanthone derivative, on two different categories of colon preneoplastic lesions induced by 1, 2-dimethylhydrazine in the rat. Asian Pac. J. Cancer Prev. 2004, 5, 433-438.
11. Chaivisuthangkura, A., Malaikaew, Y., Chaovanalikit, A., Jaratrungtawee, A. et al., Xanthone composition of Garcinia mangostana (mangosteen) fruit hull. Chromatographia 2009, 69, 315-318.
12. Jung, H. A., Su, B. N., Keller, W. J., Mehta, R. G. et al., Antioxidant xanthones from the pericarp of Garcinia mangostana (mangosteen). J. Agric. Food Chem. 2006, 54, 2077-2082.
13. Reeves, P. G., Nielsen, F. H., Fahey, G. C., AIN-93 purified diet for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123, 1939-1951.
14. Jensen, R. L., Leppla, D., Rokosz, N., Wurster, R. D., Matrigel augments xenograft transplantation of meningioma cells into athymic mice. Neurosurgery 1998, 42, 130-136.
15. Mehrara, E., Forssell-Aronsson, E., Ahlman, H., Bernhardt, P., Specific growth rate versus doubling time for quantitative characterization of tumor growth rate. Cancer Res. 2007, 67, 3970-3975.
16. Walsh, K. R., Haak, S. J., Bohn, T., Tian, Q. et al., Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies. Am. J. Clin. Nutr. 2007, 85, 1050-1056.
17. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
18. Kim, Y. S., Milner, J., Dietary modulation of colon cancer risk. J. Nutr. 2007, 137, 2576S-2579S.
19. Shan, T., Ma, Q., Guo, K., Liu, J. et al., Xanthones from mangosteen as natural chemopreventive agents: potential anticancer drugs. Curr. Mol. Med. 2011, 11, 666-677.
20. Johnson, J. J., Petiwala, S. M., Syed, D. N., Rasmussen, J. T. et al., α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis 2012, 33, 413-419.
21. Shibata, M. A., Linuma, M., Morimoto, J., Kurose, H. et al., α-Mangostin extracted from the pericarp of the mangosteen (Garcinia mangostana Linn) reduces tumor growth and lymph node metastasis in an immunocompetent xenograft model of metastatic mammary cancer carrying a p53 mutation. BMC Med. 2011, 9, 1-18.
22. Watanapokasin, R., Jarinthanan, F., Jerusalmi, A., Suksanrarn, S. et al., Potential of xanthones from tropical fruit mangosteen as anti-cancer agents: capase-dependent apoptosis induction in vitro and in mice. Appl. Biochem. Biotechnol. 2011, 17, 2086-2095.
23. Pedro, M., Cerqueira, F., Sousa, M. E., Nascimento, M. S. et al., Xanthones as inhibitors of growth of human cancer cell lines and their effects on the proliferation of human lymphocytes in vitro. Bioorg. Med. Chem. 2002, 10, 3725-3730.
24. Han, A. R., Kim, J. A., Lantvit, D. D., Kardono, L. S. et al., Cytotoxic xanthone constituents of the stem bark of Garcinia mangostana (mangosteen). J. Nat. Prod. 2009, 72, 2028-2031.
25. Matsumoto, K., Akao, Y., Ohguchi, K., Ito, T. et al., Xanthones induce cell-cycle arrest and apoptosis in human colon cancer DLD-1 cells. Bioorg. Med. Chem. 2005, 13, 6064-6069.
26. Nakagawa, Y., Iinuma, M., Naoe, T., Nozawa, Y. et al., Characterized mechanism of α-mangostin-induced cell death: capase-independent apoptosis with release of endo-nuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorg. Med. Chem. 2007, 15, 5620-5628.
27. Chang, H. F., Huang, W. T., Chen, H. J., Yang, L. L., Apoptotic effects of γ-mangostin from the fruit hull of Garcinia mangostana on human malignant glioma cells. Molecules 2010, 15, 8953-8966.
28. Hung, S. H., Shen, K. H., Wu, C. H., Liu, C. L. et al., α-Mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase- plasminogen expression through the JNK signaling pathway. J. Agric. Food Chem. 2009, 57, 1291-1298.
29. Shi, Y. W., Chien, S. T., Chen, P. S., Lee, J. H. et al., α-Mangostin suppresses phorbol 12-myristate 13-acetate-induced MMP-2/MMP-9 expression via αvβ-integrin/FAK/ERK and NFκB signaling pathway in human lung adenocarcinoma A549 cells. Cell Biochem. Biophys. 2010, 58, 31-44.
30. Krajarng, A., Nakamura, Y., Suksumrarn, S., Watanapokasin, R., α-Mangostin induces apoptosis in human chondrosarcoma cells through down regulation of ERK/JNK and Akt signaling pathway. J. Agric. Food Chem. 2011, 59, 5746-5754.
31. Yoo, J. H., Kang, K., Jho, E. H., Chin, Y. W. et al., α- and γ-mangostin inhibit proliferation of colon cancer cells via β-catenin gene regulation in Wnt/cGMP signaling. Food Chem. 2011, 129, 1550-1566.
32. Kondo, M., Zhang, L., Ji, H., Kou, Y. et al., Bioavailability and antioxidant activity of a xanthone-rich mangosteen (Garcinia mangostana) product in humans. J. Agric. Food Chem. 2009, 57, 8788-8792.
33. Li, L., Brunner, I., Han, A., Hamburger, M. et al., Pharmacokinetics of α-mangostin in rats after intravenous and oral application. Mol. Nutr. Food Res. 2011, 55, 1-8.
34. Kay, C. D., Kroon, P. A., Cassidy, A., The bioactivity of dietary anthocyanins is likely to be mediated by their degradation products. Mol. Nutr. Food Res. 2009, 53, S92-S101.
35. Monagas, M., Urpi-Sarda, M., Sanchez-Patan, F., Llorach, R. et al., Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and bioactivity of their metabolites. Food Funct. 2010, 1, 233-253.
36. Forester, S. C., Waterhouse, A. L., Metabolites are keys to understanding health effects of wine polyphenolics. J. Nutr. 2009, 139, 1824S-1831S.
37. Chen, L. G., Yang, L. L., Wang, C. C., Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem. Toxicol. 2008, 46, 688-693.
38. Nakatani, K., Yamakuni, T., Kondo, N., Arakawa, T. et al., γ-Mangostin inhibits inhibitor-κB kinase activity and decreases lipopolysaccharide-induced cyclooxygenase-2 gene expression in C6 rat glioma cells. Mol. Pharmacol. 2004, 66, 667-674.